A detailed history of Pathstone Holdings, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 21,844 shares of MRNA stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,844
Previous 18,809 16.14%
Holding current value
$1.2 Million
Previous $2 Million 29.39%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $307,172 - $505,661
3,035 Added 16.14%
21,844 $2.59 Million
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $294,185 - $397,806
3,446 Added 22.43%
18,809 $2 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $1.07 Million - $1.6 Million
15,363 New
15,363 $1.53 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $21.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.